Cleared Traditional

K862756 - PREGELLED INFANT DISPOSABLE ECG ELECTRODE

K862756 is the FDA 510(k) clearance for PREGELLED INFANT DISPOSABLE ECG ELECTRODE by Labeltape Meditect, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K862756 · Labeltape Meditect, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1986
Decision
15d
Days
Class 2
Risk

K862756 is an FDA 510(k) clearance for the PREGELLED INFANT DISPOSABLE ECG ELECTRODE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Labeltape Meditect, Inc. (Grand Rapids, US). The FDA issued a Cleared decision on August 6, 1986 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Labeltape Meditect, Inc. devices

Submission Details

510(k) Number K862756 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 1986
Decision Date August 06, 1986
Days to Decision 15 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 125d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 532
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K862756.
MODIFIED LIFESTAT 200
K864666 · Physio-Control Corp. · Dec 1986
MODEL FB-20 NON-INVASIVE BLOOD PRESSURE MONITOR
K861504 · Fukuda Denshi USA, Inc. · Aug 1986
AMBULATORY BLOOD PRESSURE MONITOR SPACELABS #90202
K855127 · Spacelabs, Inc. · Aug 1986
LIFESTAT 100
K853561 · Physio-Control Corp. · Jun 1986
HORIZON 2000 NON-INVASIVE BLOOD PRESSURE CAP.
K854942 · Mennen Medical, Inc. · Jun 1986
DINAMAP VITAL SIGNS MONITOR MODEL 8100
K854434 · Critikon Company, LLC · May 1986